Rachel Prins

Years Active: 2020-2024
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Sylvain Simon, Grace Bugos, Rachel Prins, Anusha Rajan, Arulmozhi Palani, Kersten Heyer, Andrew Stevens, Longhui Zeng, Kirsten Thompson, Jason P Price, Mitchell K Kluesner, Carla Jaeger-Ruckstuhl, Tamer B Shabaneh, James M Olson, Xiaolei Su, Stanley R Riddell
Sensitive bispecific chimeric T cell receptors for cancer therapy. Research square (2024)
Stanley Riddell, Sylvain Simon, Grace Bugos, Rachel Prins, Anusha Rajan, Arulmozhi Palani, Kersten Heyer, Andrew Stevens, Longhui Zeng, Kirsten Thompson, Jason Price, Mitchell Kluesner, Carla Jaeger-Ruckstuhl, Tamer Shabaneh, James M Olson, Xiaolei Su
Sensitive bispecific chimeric T cell receptors for cancer therapy. Research square (2024)
Anna M Bruchez, Ky Sha, Joshua C Johnson, Li Chen, Caroline Stefani, Hannah McConnell, Lea Gaucherand, Rachel Prins, Kenneth A Matreyek, Adam J Hume, Elke Mühlberger, Emmett V Schmidt, Gene G Olinger, Lynda M Stuart, Adam Lacy-Hulbert
MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses. Science (New York, N.Y.) 370 (6513) (2020)

Rachel Prins.css-eqlu8i{font-size:small;padding-left:4px;}